Abstract
Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis.
José A Pinto, Ignacio Rego, Manuel Rodríguez-Gomez, Juan D Cañete, Carlos Fernandez-López, Mercedes Freire, Jose L Fernandez-Sueiro, Raimon Sanmarti and Francisco J Blanco
The Journal of Rheumatology January 2008, 35 (1) 177-178;
José A Pinto
Ignacio Rego
Manuel Rodríguez-Gomez
Juan D Cañete
Carlos Fernandez-López
Mercedes Freire
Jose L Fernandez-Sueiro
Raimon Sanmarti
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis.
José A Pinto, Ignacio Rego, Manuel Rodríguez-Gomez, Juan D Cañete, Carlos Fernandez-López, Mercedes Freire, Jose L Fernandez-Sueiro, Raimon Sanmarti, Francisco J Blanco
The Journal of Rheumatology Jan 2008, 35 (1) 177-178;
Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis.
José A Pinto, Ignacio Rego, Manuel Rodríguez-Gomez, Juan D Cañete, Carlos Fernandez-López, Mercedes Freire, Jose L Fernandez-Sueiro, Raimon Sanmarti, Francisco J Blanco
The Journal of Rheumatology Jan 2008, 35 (1) 177-178;